Compound traditional Chinese medicine formula for treating cardio-cerebral vessel embolism
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A cardiovascular and cerebrovascular and embolization technology, which is applied in the field of compound Chinese medicine formula, can solve the problems of large body side effects, ineffective treatment, high treatment cost, etc., achieve simple administration, protect vascular endothelial cells, and reduce the occurrence of cardiovascular and cerebrovascular diseases Effect
Inactive Publication Date: 2016-07-13
李新民
View PDF0 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, people usually go to the hospital every year to use infusion to dredge the blood vessels in an attempt to reduce or avoid the occurrence of thrombotic diseases, but the infusion treatment has relatively large side effects on the body, and the treatment cost is high, and the treatment effect is not obvious
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0014] A compound traditional Chinese medicine formula for preventing and treating cardiovascular and cerebrovascular embolism in this embodiment includes the following raw materials: 4g of tempeh extract, 8g of sea cucumber extract, 4g of leech extract, 3g of sea intestine extract, 3g of salvia miltiorrhiza extract, astragalus Extract 8g, coenzyme Q1090mg, procyanidins 180mg, sodium selenite 70mg, vitamin A1800IU, vitamin B228mg, folic acid 25-35mg, lecithin 5g, L-carnitine 800mg;
Embodiment 2
[0016] A compound traditional Chinese medicine formula for preventing and treating cardiovascular and cerebrovascular embolism in this embodiment includes the following raw materials in parts by mass: Tianbei extract 6g, sea cucumber extract 12g, leech extract 6g, sea intestine extract 8g, salvia miltiorrhiza extract 8g, astragalus extract 13g, coenzyme Q10110mg, proanthocyanidins 220mg, sodium selenite 110mg, vitamin A2200IU, vitamin B232mg, folic acid 35mg, lecithin 7g, L-carnitine 1100mg.
Embodiment 3
[0018] A compound traditional Chinese medicine formula for preventing and treating cardiovascular and cerebrovascular embolism in this embodiment includes the following raw materials in parts by mass: 5 g of tempeh extract, 10 g of sea cucumber extract, 5 g of white willow bark extract, 5 g of salvia miltiorrhiza extract, and astragalus extract 10g, coenzyme Q10100mg, proanthocyanidin 200mg, sodium nitrite 100mg, vitamin A2000IU, vitamin B230mg, folic acid 30mg, vitamin C1000mg, hyaluronic acid 1g, lecithin 6g, L-carnitine 1000mg, leech extract 5g, sea intestine extract 5g, vitamin E200IU, fungus extract 5g.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a compound traditional Chinese medicine formula for treating cardio-cerebral vessel embolism and belongs to the technical field of traditional Chinese medicine formulas.The compound traditional Chinese medicine formula for treating cardio-cerebral vessel embolism comprises, by mass, 4-6 g of tempeh extract, 8-12 g of sea cucumber extract, 4-6 g of hirudo extract, 3-8 g of Urechis unicinctus extract, 3-8 g of Radix Salviae Miltiorrhizae extract, 8-13 g of Radix Astragali extract, 90-110 mg of coenzyme Q10, 180-220 mg of procyanidine, 70-110 mg of sodium selenite, 1800-2200 IU of vitamin A, 28-32 mg of vitamin B2, 25-35 mg of folic acid, 5-7 g of lecithin and 800-1100 mg of carnitine.The compound traditional Chinese medicine formula for treating cardio-cerebral vessel embolism is reasonable in design, good in treating effect by combining traditional Chinese medicines with dietetic invigoration, low in price and free of side effect.
Description
technical field [0001] The invention relates to a composite traditional Chinese medicinal formula for preventing and treating cardiovascular and cerebrovascular embolism, and belongs to the technical field of traditional Chinese medicinal formulas. Background technique [0002] Cardiovascular and cerebrovascular disease is a common disease that seriously threatens the health of human beings, especially middle-aged and elderly people over 50 years old. It has the characteristics of high prevalence, high disability rate and high mortality rate. However, there are still more than 50% of survivors of cerebrovascular accidents who cannot take care of themselves completely. The number of people who die from cardiovascular and cerebrovascular diseases in the world is as high as 15 million every year, ranking first among various causes of death. At present, people usually go to the hospital every year to use infusion to dredge the blood vessels in an attempt to reduce or avoid the o...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more